Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More engineering services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Centers for Structural Biology of HIV and Other Infectious…

U.S. National Institutes of Health·United States of America

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027$2M – $3.5MGrants Notice
Get bids like this by emailBid source

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to fund multidisciplinary U54 Centers for Structural Biology focused on HIV and other infectious diseases. Centers will determine high‑resolution 3‑D structures of viral and host biomolecules, develop computational and experimental tools, and provide shared core resources, training, and collaborative development awards to the broader research community. Funding is provided as a cooperative agreement (U54) with an estimated total award pool of $33 M and a ceiling of $3.5 M per center. Eligible applicants include U.S. public and private nonprofit institutions, for‑profit entities (excluding small businesses), and various government entities; foreign organizations are not eligible. The award period is expected to begin July 1 2027, with a submission deadline of May 28 2027. • Supports high‑resolution structural biology, computational modeling, and structure‑guided drug design. • Requires a Data Management & Sharing Plan and annual RPPR reporting. • Provides shared core facilities, training, and collaborative development awards (1‑3 CDAs per year). • Cooperative agreement implies substantial NIH programmatic involvement. • Applicants must be U.S. entities; foreign sub‑awards are prohibited. • Total anticipated funding $33 M; individual center award up to $3.5 M over multiple years.

Attached files

Contact

Nawall Kertache(Scientific/Research Contact)

[email protected]

(877) 464-4772

Key dates

Opened
12/22/2025
Closes
5/28/2027
Projected award
7/1/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Engineering Services
NAICS
541715
Solicitation №
RFA-AI-28-031

Budget estimate

$2,000,000 – $3,500,000

The NOFO lists an estimated total funding of $33 million for the entire solicitation and an award ceiling of $3.5 million per center. Assuming the typical award range for a U54 center is between $2 million and the $3.5 million ceiling, the client could expect to earn roughly $2–3.5 million per award, depending on the size of the grant, number of years (often 3–5 years), and scope of core services provided. Larger, well‑positioned institutions may receive the full ceiling, while newer or smaller consortia may receive nearer the lower end.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 88%

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

86% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

86% match

Centers for Research on Neglected Infectious Diseases

Closes 6/14/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

85% match

Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

85% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. National Institutes of Health·United States of America

85% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

84% match

HIV/AIDS Clinical Trials Network Clinical Trials Units

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

84% match

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 12/29/2025

U.S. National Institutes of Health·United States of America

84% match

HIV/AIDS Clinical Trials Network Leadership and Operations Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

84% match

HIV/AIDS Clinical Trials Network Statistical and Data Management Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

84% match

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Closes 5/24/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

84% match

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

84% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

83% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

83% match

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Closes 6/7/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

83% match

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)

Closes 10/17/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

83% match

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)

Closes 10/27/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

83% match

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/12/2025

U.S. National Institutes of Health·United States of America

83% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

83% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

82% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

82% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. National Institutes of Health·United States of America

82% match

Implementation and Evaluation of Databases to Examine AIDS

Closes 5/26/2027Opened 5/27/2025

U.S. National Institutes of Health·United States of America

82% match

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

Closes 11/5/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

82% match

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Closes 7/5/2029Opened 6/27/2025